Investors’ hunger for obesity drugs is unsatiated. Roche’s share price jumped by 6 per cent this week after the Swiss company announced promising early stage trial data from a potential obesity drug.
投资者对肥胖症药物的渴求尚未得到满足。罗氏(Roche)本周宣布了一种潜在肥胖症药物的早期试验数据，显示出前景看好，其股价随之上涨了6%。
您已阅读8%（270字），剩余92%（3281字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。